These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37401236)

  • 1. Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation.
    Zhou W; Feng Y; Lin C; Chao CK; He Z; Zhao S; Xue J; Zhao XY; Cao W
    Adv Sci (Weinh); 2023 Sep; 10(25):e2207549. PubMed ID: 37401236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
    Yao Y; Liu Y; Jin F; Meng Z
    Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
    Yu Q; Du Y; Wang S; Zheng X
    J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.
    He L; Liao L; Du L
    Int J Mol Med; 2020 Aug; 46(2):828-838. PubMed ID: 32626925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
    Wu Y; Zhang L; Zhang L; Wang Y; Li H; Ren X; Wei F; Yu W; Liu T; Wang X; Zhou X; Yu J; Hao X
    Int J Oncol; 2015; 46(6):2586-94. PubMed ID: 25901533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
    Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
    Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3.
    Hu Y; Lv F; Li N; Yuan X; Zhang L; Zhao S; Jin L; Qiu Y
    FEBS Open Bio; 2023 Jan; 13(1):195-208. PubMed ID: 36468944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00152 promotes oral squamous cell carcinoma growth via enhancing Upstream Transcription Factor 1 mediated Mitochondrial Ribosomal Protein L52 transcription.
    Zou X; Hu X; He F; Zhang M; Kong X; Rui S; Liu Y; Wang L; Zheng X; Liu J; Li Z; Luo H
    J Oral Pathol Med; 2022 May; 51(5):454-463. PubMed ID: 34664331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Axis between the Long Non-Coding RNA
    Nakashima C; Fujiwara-Tani R; Mori S; Kishi S; Ohmori H; Fujii K; Mori T; Miyagawa Y; Yamamoto K; Kirita T; Luo Y; Kuniyasu H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1.
    Xing HB; Qiu HM; Li Y; Dong PF; Zhu XM
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4777-4783. PubMed ID: 31210307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG6 promotes oesophageal squamous cell carcinoma by downregulating the miR-101-3p/EZH2 pathway.
    Zhang Y; Li R; Ding X; He M; Zhang R
    J Biochem Mol Toxicol; 2022 Feb; 36(2):e22959. PubMed ID: 34766670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y; Shuai Y; Wang H; Li H; Li Y
    Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.